WilliamE.CarsonIIIMD

PubMed

• Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma.
  Emily M Ringwalt, Mark A Currier, Andrea M Glaspell, Chun-Yu Chen, Matthew V Cannon
  Molecular Therapy. Oncology. 2024-12-19
• Low Hospital Volume Is Associated with Higher All-Cause Mortality in Black Women with Triple Negative Breast Cancer.
  Samilia Obeng-Gyasi, Demond Handley, Mohamed I Elsaid, Saurabh Rahurkar, Barbara L Andersen
  Journal of Racial and Ethnic Health Disparities. 2024-12-01
• 1 citations
  Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
  Bhavana Konda, Eric J Sherman, Erminia Massarelli, Jorge Nieva, Jameel Muzaffar
  The Journal of Clinical Endocrinology and Metabolism. 2024-08-12

Journal Articles

• Fluorescent nanodiamonds and their use in biomedical research  
  Suarez-Kelly L, Rampersaud I, Moritz C, Campbell A, Hu Z, Alkahtani M, Alghannam F, Helmer, P, Carson, WE 3rd, Rampersaud A, Proc. SPIE 9762, Advances in Photonics of Quantum Computing, Memory, and Communication IX, 1/1/2016
•  
  Ren L, Campbell A, Fang H, Gautam S, Elavazhagan S, Fatehchand K, Mehta P, Stiff A, Reader BF, Mo X, Byrd JC, Carson WE 3rd, Butchar JP, Tridandapani S, J Biol Chem, 1/1/2016
• Melanoma, Version 22016, NCCN Clinical Practice Guidelines in Oncology  
  Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Ho..., J Natl Compr Canc Netw, 1/1/2016
• NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines  
  Jaime-Ramirez AC, McMichael EL, Kondadasula S, Skinner CC, Mundy-Bosse BL, Luedke E, Jones NB, Mani A, Roda J, Karpa V, Li H, Li J, Elavazhagan S, La Perle KM, Schmitt..., Cancer Immunol Res, 1/1/2016
• Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment  
  Stiff A, Trikha P, Wesolowski R, Kendra K, Hsu V, Uppati S, McMichael E, Duggan M, Campbell A, Keller K, Landi I, Zhong Y, Dubovsky J, Howard JH, Yu L, Harrington B, O..., Cancer Res, 1/1/2016
• Structural characterization of NRAS isoform 5  
  Markowitz J, Mal TK, Yuan C, Courtney NB, Patel M, Stiff AR, Blachly J, Walker C, Eisfeld AK, de la Chapelle A, Carson WE 3rd, Protein Sci, 1/1/2016
• A Progenitor Cell Expressing Transcription Factor RORgammat Generates All Human Innate Lymphoid Cell Subsets  
  Scoville SD, Mundy-Bosse BL, Zhang MH, Chen L, Zhang X, Keller KA, Hughes T, Chen L, Cheng S, Bergin SM, Mao HC, McClory S, Yu J, Carson WE 3rd, Caligiuri MA, Freud AG, Immunity, 1/1/2016
• A Comprehensive Program for the Enhancement of Accrual to Clinical Trials  
  Porter M, Ramaswamy B, Beisler K, Neki P, Single N, Thomas J, Hofacker J, Caligiuri M, Carson WE 3rd, Ann Surg Oncol, 1/1/2016
• NKp80 Defines a Critical Step during Human Natural Killer Cell Development  
  Freud AG, Keller KA, Scoville SD, Mundy-Bosse BL, Cheng S, Youssef Y, Hughes T, Zhang X, Mo X, Porcu P, Baiocchi RA, Yu J, Carson WE 3rd, Caligiuri MA, Cell Rep, 1/1/2016
• A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma  
  Liu JQ, Talebian F, Wu L, Liu Z, Li MS, Wu L, Zhu J, Markowitz J, Carson WE 3rd, Basu S, Bai XF, J Immunol, 1/1/2016
• Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions  
  Skinner CC, McMichael EL, Jaime-Ramirez AC, Abrams ZB, Lee RJ, Carson WE 3rd, Melanoma Res, 1/1/2016
• NCCN Guidelines Insights: Melanoma, Version 32016  
  Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Jose..., J Natl Compr Canc Netw, 1/1/2016
• MicroRNA dysregulation in melanoma  
  Latchana N, Ganju A, Howard JH, Carson WE 3rd, Surg Oncol, 1/1/2016
• A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer  
  Bertino EM, McMichael EL, Mo X, Trikha P, Davis M, Paul B, Grever M, Carson WE 3rd, Otterson GA, Mol Cancer Ther, 1/1/2016
• MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches  
  Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, O..., Onco Targets Ther, 1/1/2016
• Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors  
  Latchana N, Regan K, Howard JH, Aldrink JH, Ranalli MA, Peters SB, Zhang X, Gru A, Payne PR, Suarez-Kelly LP, Carson WE 3rd, J Surg Res, 1/1/2016
• Interferon-gamma promotes antibody-mediated fratricide of acute myeloid leukemia cells  
  Fatehchand K, McMichael EL, Reader BF, Fang H, Santhanam R, Gautam S, Elavazhagan S, Mehta P, Buteyn NJ, Merchand-Reyes G, Vasu S, Mo X, Benson DM, Blachly JS, Carson ..., J Biol Chem, 1/1/2016
• MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 Inhibitor  
  Martin del Campo SE, Latchana N, Levine KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI, Carson M, Ganju A, Chan AN, Carson WE 3rd, PLoS One, 1/1/2015
• Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease  
  Markowitz J, Brooks TR, Duggan MC, Paul BK, Pan X, Wei L, Abrams Z, Luedke E, Lesinski GB, Mundy-Bosse B, Bekaii-Saab T, Carson WE 3rd, Cancer Immunol Immunother, 1/1/2015
• PTEN Is a Negative Regulator of NK Cell Cytolytic Function  
  Briercheck EL, Trotta R, Chen L, Hartlage AS, Cole JP, Cole TD, Mao C, Banerjee PP, Hsu HT, Mace EM, Ciarlariello D, Mundy-Bosse BL, Garcia-Cao I, Scoville SD, Yu L, P..., J Immunol, 1/1/2015
• RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenviroment  
  Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE 3rd, Ganju RK, Cancer Res, 1/1/2015
• The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells  
  Martin del Campo SE, Levine KM, Mundy-Bosse BL, Grignol VP, Fairchild ET, Campbell AR, Trikha P, Mace TA, Paul BK, Jaime-Ramirez AC, Markowitz J, Kondadasula SV, Guent..., J Immunol, 1/1/2015
• Predicting Overall Survival in Patients With Metastatic Melanoma on Antiangiogenic Therapy and RECIST Stable Disease on Initial Posttherapy Images Using CT Texture Ana...  
  Smith AD, Gray MR, del Campo SM, Shlapak D, Ganeshan B, Zhang X, Carson WE 3rd, AJR Am J Roentgenol, 1/1/2015
• Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12  
  Campbell AR, Regan K, Bhave N, Pattanayak A, Parihar R, Stiff AR, Trikha P, Scoville SD, Liyanarachchi S, Kondadasula SV, Lele O, Davuluri R, Payne PR, Carson WE 3rd, BMC Med Genomics, 1/1/2015
• Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology  
  Shu D, Li H, Shu Y, Xiong G, Carson WE 3rd, Haque F, Xu R, Guo P, ACS Nano, 1/1/2015
• Join now to see all

Books/Book Chapters

• Regulation of Innate Immune Function 
  Chapter: The role of natural killer cells in innate immunity 
  Bhave N, Carson WEEditors: Clay, MB, Tridandapani S, Piper, MG.Transworld Research Network, Kerala, India2010
• Cytokines in the Genesis and Treatment of Cancer 
  Chapter: The type I intereron family 
  Moschos S, Lesinski GB, Carson WE, Kirkwood JMEditors: Caligiuri MA and Lotze MT.Humana Press2007
• Cytokines and Cancer 
  Chapter: Novel cytokines in the treatment of malignancy 
  Parihar R, Carson WEEditors: Leonidas C. Platanias.Kluwer Academic Press2004
• Tumor Models in Cancer 
  Chapter: Animal models of malignant melanoma 
  Page 471.0 - 492.0Carson WE, Walker MJEditors: Teicher BA.Human Press, Totowa, NJ2001
• Cytokines: Health and Disease 
  Chapter: Interleukin 15 
  Page 209.0 - 221.0Carson WE, Caligiuri MAEditors: Remick D.Academic Press1997
• Methods: A Companion to Methods in Enzymology 
  Chapter: Natural killer cell subsets and development 
  Carson WE, Caligiuri MAAcademic Press1996
• Cell Therapy 
  Chapter: Cellular adoptive immunotherapy with natural killer cells 
  Page 451.0 - 474.0Carson WE, Caligiuri, MAEditors: Morstyn G, Sheridan B.Cambridge University Press1996
• Join now to see all

Abstracts/Posters

• Anterior flap hemipelvectomy
  Karakousis CP, Mamounas E, Carson WE, Society of Surgical Oncology, 46th Cancer Symposium, Cine Clinic, Los Angeles, CA, 1/1/1993

Lectures

• Clinical Use of Cytokines 
  1/1/2017
• Natural Killer Cells and gamma delta T Cells 
  1/1/2017
• Cellular and Molecular Immunology 
  1/1/2017
• The Innate Immune System 
  1/1/2017
• Update on Cytokines 
  1/1/2017
• Angiogenesis 
  1/1/2017
• Tumor Immunology 
  1/1/2017
• Cancer Epidemiology and Prevention 
  Ohio State University School of Medicine - 1/1/2017
• Immunology 
  Ohio State University School of Medicine - 1/1/2017
• Interferons in the Treatment of Urologic Cancers 
  1/1/2001
• Cytokine Therpay of Melanoma 
  1/1/2001
• Melanoma Trials 
  1/1/2001
• Cancer Detection 
  Ohio State University School of Medicine - 1/1/1999
• Breast Cancer: Detection and Current Therapy 
  1/1/1998
• The Role of Interleukin-15 in NK Cell Biology 
  1/1/1998
• Suppressors of Cytokine Signaling: A pair of SOCS 
  Nordwijk, Netherlands - 1/16/2006
• Performance Enhancing Drugs for Antibody Therapy 
  Los Angeles, CA - 1/30/2014
• Trial Design for Cytostatic Agents 
  Helen F. Graham Cancer Center at Chr, New Orleans, LA - 1/4./2004
• MicroRNAs in Melanoma 
  Wilmington, DE - 1/27/2008
• Controversies in Clinical Research 
  1/19/2008
• Interleukin-21 
  New York, NY - 1/26/2009
• Protesome Inhibition in Clinical Practice 
  Boston, MA - 1/4./2009
• A Comprehensive Program for The Enhancement of Accrual to Therapeutic Clinical Trials 
  Washington, DC - 1/29/2010
• Adventures in Tissue Acquisition 
  Washington, DC - 1/13/2010
• Monoclonoal Antibody Therapy of Cancer 
  Gwangju City, South Korea - 1/26/2010
• Join now to see all